For investors & strategic partners
Back a first-in-class microbiome platform with clinical proof.
Microbiome-as-a-Drug across two high-unmet-need tracks — CNS and oncology — built on a 300+ strain library, industrialized FMT 3.0, and AI-native discovery.
300+
Reserved functional strains
5+
World medical records
10,000+
FMT & assays performed
The opportunity
Why now
The microbiome is moving from supplements to a programmable drug class. We pair an industrialized FMT 3.0 process (P2 + GMP) with a proprietary strain library and AI-native discovery to pursue indications where standard care leaves large gaps — depression & mood disorders, and immune-checkpoint sensitization in “cold” tumors.
Pipeline
Full pipeline →Major depressive disorder & mood disorders
Live biotherapeutic (Bifidobacterium longum strain) / FMT 3.0 · Preclinical
Next: IND-enabling studies
pMMR / MSS colorectal cancer (ICI-refractory)
FMT 3.0 + immune-checkpoint inhibitor combination · Discovery
Next: Investigator-led cohort expansion
Proof points
All evidence →Onco · Stage IVB pMMR/MSS colorectal cancer
Complete remission achieved — first reported case globally.
Source: Cureus, 2024
CNS · Insomnia / sleep disturbance with anxiety
Improved sleep quality reported across the case series; mechanism discussed via serotonin, metabolites and immune-inflammatory pathways.
Source: Internal case series, 2023
Qualifications
-
National High-Tech Enterprise
HNTE-certified
-
Certified laboratory
P2 + GMP · >1,000 m² floor area
-
Import/export special-items whitelist
Shenzhen 2025 pilot — one of only 5 pharma firms citywide
-
State-lab incubation
Shenzhen Bay Laboratory · Pingshan Biomedical Translation Center
-
100+ IP assets
Proprietary strain registrations + patent portfolio
-
Peer-reviewed SCI publications
Including BMC Bioinformatics (microbiome × AI)
Ways to partner
Equity investment
Strategic and financial investors backing a first-in-class microbiome platform.
Licensing & co-development
Program-level partnerships across CNS and oncology assets.
Clinical & manufacturing
Hospital collaborations and FMT 3.0 supply via our P2 + GMP facility.
Let’s talk
Request the investor brief.
A gated data room is on the roadmap; for now we share materials on request. Tell us who you are and what stage of conversation you’re ready for.
Form integration pending.
Configure site.contact.formspreeId in
src/data/site.ts with your Formspree form ID
to enable this form (free at formspree.io).